Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Press Releases
Welcome to our press release archive. To learn more about how we work with healthcare and business reporters worldwide, or if you are looking for specific data and expert insights to support a current story, please contact us at media@evaluate.com.
Latest Press Releases
MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making
LONDON, BOSTON, TOKYO (September 28, 2021) - The move will result in a disruptive, market-leading analytics platform that provides on-demand insights across dozens of…
MMIT and Evaluate Join Forces to Offer an End-to-End View of the Pharmaceutical Market Landscape
LONDON, BOSTON, TOKYO (August 20, 2021) – By combining their technology, data and expertise, MMIT and Evaluate will become a $1.6 billion global pharma commercial…
Evaluate Group Limited appoints Cem Baydar as Chief Consulting Officer
LONDON, BOSTON, TOKYO (June 21, 2021) – Evaluate, a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, is pleased to…
Browse the archive
Biopharma in 2018: A year of contrasts as stocks and M&A slump, but venture financing and IPOs remain strong
Evaluate Vantage releases annual analysis of Pharma, Biotech and Medtech performance
Uncertainty for pharma and biotech in 2019 as sector stumbles at the end of 2018
Vantage’s Annual Pharma and Biotech Preview explores what’s in store for 2019
Worldwide medtech sales forecast to reach $595 billion by 2024, with a CAGR of 5.6%, anchored by familiar players
Evaluate Ltd. releases annual “EvaluateMedtech World Preview 2018, Outlook to 2024” in conjunction with The Medtech Conference
Small drug developers continue to hold all the cards, while young device makers suffer from a shrinking pool of buyers
Vantage releases its half-year analysis of sector performance: Pharma, Biotech and Medtech Half-Year Review 2018
Worldwide Prescription Drug Sales Accelerate To $1.2 Trillion By 2024, As Unmet Need Drives Annual Compound Growth To Over 6%
Eleventh annual EvaluatePharma World Preview 2018, Outlook to 2024 report launches at BIO 2018.
Worldwide Orphan Drug Sales Are Forecast To Grow At A Cagr Of 11.3% From 2018 To 2024, Double The Rate Forecast For The Non-Orphan Drug Market
Annual “EvaluatePharma Orphan Drug 2018 Report” sees Orphan drugs capture a fifth of worldwide prescription sales by 2024 as sales grow to $262bn.
Fast Pace Of Drug And Device Approvals In 2017 Signals Wider Sector Health For Biopharma But Medtech Companies Struggle
EP Vantage releases its annual analysis of sector performance: Pharma, Biotech and Medtech 2017 in Review.
Uptick In M&A Activity And Investor Cash Expected To Re-Invigorate Pharma And Biotech In 2018
EP Vantage’s Annual Pharma and Biotech Preview explores what’s in store for 2018.
Worldwide Medtech Sales Forecast To Reach $522 Billion By 2022 With A Cagr Of 5.1% Between 2016 And 2022
EvaluateMedTech Report Launches in Conjunction with The MedTech Conference.
